Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 14, 2024 | Human | Unknown | Oclacitinib Maleate | Dizziness; Accidental exposure | Outcome Unknown |
| Mar 14, 2024 | Human | Unknown | Moxidectin | Vials, Abnormal; Accidental exposure; No sign | Recovered/Normal |
| Mar 14, 2024 | Human | Unknown | Buprenorphine | Tingling skin | Ongoing |
| Mar 14, 2024 | Human | Unknown | Fenbendazol Granules | Throat pain; Sinus pain; Nasal discharge; Migraine; Emesis (multiple) | Ongoing |
| Mar 13, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Localised rash; Swollen eye | Ongoing |
| Mar 13, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Warm feeling to the touch; Generalised rash; Dermatitis; Vascular dilation an... | Ongoing |
| Mar 13, 2024 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error NOS; Closure, Abnormal; Acciden... | Recovered/Normal |
| Mar 12, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Closure, Abnormal; Accidental exposure; Medicati... | Recovered/Normal |
| Mar 11, 2024 | Human | Unknown | Ivermectin | Local swelling (not application site); High blood pressure; Accidental exposure | Outcome Unknown |
| Mar 11, 2024 | Human | Unknown | Moxidectin | Injection site swelling; Accidental exposure | Ongoing |
| Mar 8, 2024 | Human | Unknown | Oclacitinib Maleate | Nausea; Accidental exposure | Outcome Unknown |
| Mar 8, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Ongoing |
| Mar 7, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Injection site pain | Outcome Unknown |
| Mar 6, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error NOS; Accidental exposure | Recovered/Normal |
| Mar 5, 2024 | Human | Unknown | Oclacitinib Maleate | Vertigo | Recovered/Normal |
| Mar 5, 2024 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error NOS; Containers, Leaking; Produ... | Recovered/Normal |
| Mar 5, 2024 | Human | Unknown | Imidacloprid, Moxidectin | Swollen lip (see also Skin); Accidental exposure | Ongoing |
| Mar 4, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Ongoing |
| Mar 4, 2024 | Human | Unknown | Omeprazole | Anaphylaxis | Outcome Unknown |
| Mar 4, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Outcome Unknown |
| Mar 2, 2024 | Human | Unknown | Praziquantel; Emodepside | Hives (see also Skin); Cough; Reddening of the skin; Itching; Accidental expo... | Outcome Unknown |
| Mar 1, 2024 | Human | Unknown | Ophytrium | Swollen eye; Odor, Abnormal | Outcome Unknown |
| Mar 1, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Injection site pain | Outcome Unknown |
| Feb 29, 2024 | Human | Unknown | Selamectin;Sarolaner | Oedematous erythema; Pinnal erythema; Accidental drug intake by child | Outcome Unknown |
| Feb 27, 2024 | Human | Unknown | Melarsomine Dihydrochloride | Eye irritation; Application site irritation; Accidental exposure; Incorrect r... | Recovered/Normal |
| Feb 26, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Product defect, product dif... | Recovered/Normal |
| Feb 26, 2024 | Human | Unknown | Altrenogest Oily Solution | Headache; Night sweat | Ongoing |
| Feb 24, 2024 | Human | Unknown | Cefovecin | Needlestick injury; Injection site pruritus | Outcome Unknown |
| Feb 23, 2024 | Human | Unknown | Buprenorphine | Heavy sweating; Fatigue; Malaise | Recovered/Normal |
| Feb 23, 2024 | Human | Unknown | Flunixin Meglumine Injectable | Eye redness; Eye irritation | Recovered/Normal |
| Feb 23, 2024 | Human | Unknown | Enrofloxacin | Needlestick injury; Accidental exposure | Outcome Unknown |
| Feb 23, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site burning sensation | Ongoing |
| Feb 23, 2024 | Human | Unknown | Melarsomine Dihydrochloride | Injection site bleeding; Accidental exposure | Recovered/Normal |
| Feb 22, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Ongoing |
| Feb 22, 2024 | Human | Unknown | Fenbendazol Granules | Nausea | Ongoing |
| Feb 21, 2024 | Human | Unknown | Polysulfated Glycosaminoglycan | Bruising; Injection site swelling; Injection site tingling | Recovered/Normal |
| Feb 21, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury | Outcome Unknown |
| Feb 20, 2024 | Human | Unknown | Velagliflozin Proline Monohydrate | Hypoglycaemia; Accidental exposure | Recovered/Normal |
| Feb 19, 2024 | Human | Unknown | Monensin Sodium | Eye irritation; Accidental exposure; Eye redness | Recovered/Normal |
| Feb 18, 2024 | Human | Unknown | Selamectin;Sarolaner | Rash; Hives (see also Skin); Accidental exposure; Hypersensitivity reaction | Outcome Unknown |
| Feb 15, 2024 | Human | Unknown | Velagliflozin Proline Monohydrate | Localised rash; Localised itching; Accidental exposure | Outcome Unknown |
| Feb 14, 2024 | Human | Unknown | Eprinomectin; Praziquantel | Application site numbness; Accidental exposure | Recovered/Normal |
| Feb 14, 2024 | Human | Unknown | Velagliflozin Proline Monohydrate | Uncoded sign; Vials, Damaged | Recovered/Normal |
| Feb 13, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury | Outcome Unknown |
| Feb 13, 2024 | Human | Unknown | Oclacitinib Maleate | Nausea; Accidental exposure | Outcome Unknown |
| Feb 9, 2024 | Human | Unknown | Meloxicam | Itching; Accidental drug intake by child | Recovered/Normal |
| Feb 9, 2024 | Human | Unknown | Mirtazapine | Numbness; Medication error NOS | Recovered/Normal |
| Feb 9, 2024 | Human | Unknown | Mirtazapine | Medication error NOS; Fever; General illness; Nausea; Tiredness | Outcome Unknown |
| Feb 8, 2024 | Human | Unknown | Maropitant Citrate | Chest tightness; Headache; Accidental exposure; Incorrect route of drug admin... | Outcome Unknown |
| Feb 8, 2024 | Human | Unknown | Maropitant Citrate | Chest tightness; Headache; Accidental exposure | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.